Fig. 5From: Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysisTitle: Adverse events, injection site reactions. There was no significant difference in the injection site reaction between the treated and placebo groups. Subgroup analysis revealed a significant increase in the drisapersen group, but not in the eteplirsen group, compared with that in the placebo groupsBack to article page